260 related articles for article (PubMed ID: 21116766)
1. Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.
Merelli A; Caltana L; Girimonti P; Ramos AJ; Lazarowski A; Brusco A
Neurotox Res; 2011 Aug; 20(2):182-92. PubMed ID: 21116766
[TBL] [Abstract][Full Text] [Related]
2. Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.
Merelli A; Caltana L; Lazarowski A; Brusco A
Drug Metabol Drug Interact; 2011; 26(2):65-9. PubMed ID: 21756166
[TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injection.
Caltana L; Merelli A; Lazarowski A; Brusco A
Neurotox Res; 2009 May; 15(4):348-58. PubMed ID: 19384568
[TBL] [Abstract][Full Text] [Related]
4. Moringa oleifera extract attenuates the CoCl
Abdel-Rahman Mohamed A; M M Metwally M; Khalil SR; Salem GA; Ali HA
Biomed Pharmacother; 2019 Jan; 109():1688-1697. PubMed ID: 30551423
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.
Hellewell SC; Yan EB; Alwis DS; Bye N; Morganti-Kossmann MC
J Neuroinflammation; 2013 Dec; 10():156. PubMed ID: 24344874
[TBL] [Abstract][Full Text] [Related]
6. Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity.
Merelli A; Ramos AJ; Lazarowski A; Auzmendi J
Front Neurosci; 2019; 13():750. PubMed ID: 31379495
[TBL] [Abstract][Full Text] [Related]
7. The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.
Cetin A; Nas K; Büyükbayram H; Ceviz A; Olmez G
Eur Spine J; 2006 Oct; 15(10):1539-44. PubMed ID: 16547753
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway.
Ryou MG; Liu R; Ren M; Sun J; Mallet RT; Yang SH
Stroke; 2012 Apr; 43(4):1101-7. PubMed ID: 22282883
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin Protects Retinal Cells in Diabetic Rats Through Upregulating ZnT8 via Activating ERK Pathway and Inhibiting HIF-1α Expression.
Xu G; Kang D; Zhang C; Lou H; Sun C; Yang Q; Lu L; Xu GT; Zhang J; Wang F
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8166-78. PubMed ID: 26720469
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hypoxia inducible factor-1α expression by the alteration of redox status in HepG2 cells.
Jin WS; Kong ZL; Shen ZF; Jin YZ; Zhang WK; Chen GF
J Exp Clin Cancer Res; 2011 May; 30(1):61. PubMed ID: 21595915
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning and post-treatment with cobalt chloride in rat model of perinatal hypoxic-ischemic encephalopathy.
Dai Y; Li W; Zhong M; Chen J; Liu Y; Cheng Q; Li T
Brain Dev; 2014 Mar; 36(3):228-40. PubMed ID: 23694759
[TBL] [Abstract][Full Text] [Related]
12. Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.
Li YX; Ding SJ; Xiao L; Guo W; Zhan Q
Neurosci Bull; 2008 Apr; 24(2):89-95. PubMed ID: 18369388
[TBL] [Abstract][Full Text] [Related]
13. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1α and erythropoietin expression in the hippocampus of neonatal rats following hypoxia-ischemia.
Lu J; Jiang L; Zhu H; Zhang L; Wang T
J Nanosci Nanotechnol; 2014 Aug; 14(8):5614-9. PubMed ID: 25935977
[TBL] [Abstract][Full Text] [Related]
15. Changes in kidney tissue and effects of erythropoietin after acute heart failure.
Güven Bağla A; Içkin Gülen M; Ercan F; Aşgün F; Ercan E; Bakar C
Biotech Histochem; 2018; 93(5):340-353. PubMed ID: 29671622
[TBL] [Abstract][Full Text] [Related]
16. Co-transactivation of the 3' erythropoietin hypoxia inducible enhancer by the HIF-1 protein.
Varma S; Cohen HJ
Blood Cells Mol Dis; 1997 Aug; 23(2):169-76. PubMed ID: 9236155
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokine tumor necrosis factor α suppresses neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia-inducible factor-2α.
Nagaya Y; Aoyama M; Tamura T; Kakita H; Kato S; Hida H; Saitoh S; Asai K
Eur J Neurosci; 2014 Dec; 40(11):3620-6. PubMed ID: 25283246
[TBL] [Abstract][Full Text] [Related]
18. Biology of erythropoietin.
Jelkmann W; Hellwig-Bürgel T
Adv Exp Med Biol; 2001; 502():169-87. PubMed ID: 11950137
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy.
Merelli A; Czornyj L; Lazarowski A
Curr Pharm Des; 2013; 19(38):6791-801. PubMed ID: 23530506
[TBL] [Abstract][Full Text] [Related]
20. Involvement of hypoxia-inducible factor-1 alpha in the upregulation of P-glycoprotein in refractory epilepsy.
Wang G; Xie G; Han L; Wang D; Du F; Kong X; Su G
Neuroreport; 2019 Dec; 30(17):1191-1196. PubMed ID: 31634239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
